BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

34 related articles for article (PubMed ID: 38450965)

  • 21. Retinal toxicity associated with chronic exposure to hydroxychloroquine and its ocular screening. Review.
    Geamănu Pancă A; Popa-Cherecheanu A; Marinescu B; Geamănu CD; Voinea LM
    J Med Life; 2014 Sep; 7(3):322-6. PubMed ID: 25408748
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hydroxychloroquine in systemic lupus erythematosus (SLE).
    Ponticelli C; Moroni G
    Expert Opin Drug Saf; 2017 Mar; 16(3):411-419. PubMed ID: 27927040
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Is hydroxychloroquine effective in treating primary Sjogren's syndrome: a systematic review and meta-analysis.
    Wang SQ; Zhang LW; Wei P; Hua H
    BMC Musculoskelet Disord; 2017 May; 18(1):186. PubMed ID: 28499370
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydroxychloroquine retinopathy.
    Yusuf IH; Sharma S; Luqmani R; Downes SM
    Eye (Lond); 2017 Jun; 31(6):828-845. PubMed ID: 28282061
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hydroxychloroquine in the post-COVID-19 era: will this pandemic upset decades of clinical practice?
    Pothen L; Yildiz H; Samnick MM; Yombi JC
    Clin Rheumatol; 2021 Apr; 40(4):1649-1657. PubMed ID: 33452660
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of uveitis in autoimmune diseases patients treated with hydroxychloroquine: A population-based retrospective cohort study.
    Bai YC; Perng WT; Huang JY; Liao PL; Wei JC
    Int J Rheum Dis; 2024 Mar; 27(3):e15099. PubMed ID: 38450965
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hydroxychloroquine in systemic lupus erythematosus and rheumatoid arthritis and its safety in pregnancy.
    Abarientos C; Sperber K; Shapiro DL; Aronow WS; Chao CP; Ash JY
    Expert Opin Drug Saf; 2011 Sep; 10(5):705-14. PubMed ID: 21417950
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Hydroxychloroquine for autoimmune diseases].
    Danza Á; Graña D; Goñi M; Vargas A; Ruiz-Irastorza G
    Rev Med Chil; 2016 Feb; 144(2):232-40. PubMed ID: 27092678
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Therapy and pharmacological properties of hydroxychloroquine and chloroquine in treatment of systemic lupus erythematosus, rheumatoid arthritis and related diseases.
    Rainsford KD; Parke AL; Clifford-Rashotte M; Kean WF
    Inflammopharmacology; 2015 Oct; 23(5):231-69. PubMed ID: 26246395
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hydroxychloroquine in rheumatic autoimmune disorders and beyond.
    Nirk EL; Reggiori F; Mauthe M
    EMBO Mol Med; 2020 Aug; 12(8):e12476. PubMed ID: 32715647
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hydroxychloroquine in systemic and autoimmune diseases: Where are we now?
    Dima A; Jurcut C; Arnaud L
    Joint Bone Spine; 2021 May; 88(3):105143. PubMed ID: 33515791
    [TBL] [Abstract][Full Text] [Related]  

  • 32.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 33.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 34.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]     [New Search]
    of 2.